Amy E. Levenson

407 total citations
11 papers, 299 citations indexed

About

Amy E. Levenson is a scholar working on Surgery, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Amy E. Levenson has authored 11 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 5 papers in Molecular Biology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Amy E. Levenson's work include Cholesterol and Lipid Metabolism (5 papers), Lipoproteins and Cardiovascular Health (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). Amy E. Levenson is often cited by papers focused on Cholesterol and Lipid Metabolism (5 papers), Lipoproteins and Cardiovascular Health (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). Amy E. Levenson collaborates with scholars based in United States and Spain. Amy E. Levenson's co-authors include Sudha B. Biddinger, Alexei Kharitonenkov, Shufang Wu, Sarah D. de Ferranti, Francesco De Luca, Mary E. Haas, David J. Salant, Xiaowei Sun, Joseph M. Rutkowski and Valerié Schumacher and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Amy E. Levenson

11 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amy E. Levenson United States	8	151	105	74	43	40	11	299
Ryo Kawakami Japan	9	73 0.5×	122 1.2×	34 0.5×	31 0.7×	75 1.9×	21	275
Agostino Milluzzo Italy	11	57 0.4×	106 1.0×	96 1.3×	18 0.4×	19 0.5×	20	290
Melody Chemaly United Kingdom	7	91 0.6×	180 1.7×	20 0.3×	37 0.9×	21 0.5×	18	355
Paola Conca Italy	6	328 2.2×	122 1.2×	196 2.6×	22 0.5×	63 1.6×	7	432
M.J. Savolainen Finland	6	120 0.8×	74 0.7×	127 1.7×	18 0.4×	32 0.8×	9	329
Qinhua Chen China	10	197 1.3×	100 1.0×	58 0.8×	8 0.2×	103 2.6×	14	420
Sastry Prayaga United States	7	132 0.9×	134 1.3×	69 0.9×	6 0.1×	104 2.6×	9	341
Jonas Mandel France	9	271 1.8×	36 0.3×	104 1.4×	24 0.6×	50 1.3×	13	408
Manjula Vinod France	8	95 0.6×	115 1.1×	35 0.5×	14 0.3×	40 1.0×	15	286
Javier Varona Santos United States	8	98 0.6×	140 1.3×	52 0.7×	194 4.5×	24 0.6×	11	409

Countries citing papers authored by Amy E. Levenson

Since Specialization

Citations

This map shows the geographic impact of Amy E. Levenson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy E. Levenson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy E. Levenson more than expected).

Fields of papers citing papers by Amy E. Levenson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy E. Levenson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy E. Levenson. The network helps show where Amy E. Levenson may publish in the future.

Co-authorship network of co-authors of Amy E. Levenson

This figure shows the co-authorship network connecting the top 25 collaborators of Amy E. Levenson. A scholar is included among the top collaborators of Amy E. Levenson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy E. Levenson. Amy E. Levenson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Brown, Lauren, et al.. (2023). Severe multiple organ failure as a consequence of diabetic ketoacidosis in an adolescent with new-onset type 1 diabetes: A case report. SHILAP Revista de lepidopterología. 11. 2050313X231190004–2050313X231190004. 2 indexed citations

Semova, Ivana, Amy E. Levenson, Joanna Krawczyk, et al.. (2022). Insulin Prevents Hypercholesterolemia by Suppressing 12α-Hydroxylated Bile Acids. Circulation. 145(13). 969–982. 22 indexed citations

Semova, Ivana, Amy E. Levenson, Joanna Krawczyk, et al.. (2020). Markers of cholesterol synthesis are elevated in adolescents and young adults with type 2 diabetes. Pediatric Diabetes. 21(7). 1126–1131. 7 indexed citations

Wright, Frances, et al.. (2020). Hemoglobin A_1c and fructosamine correlate in a patient with sickle cell disease and diabetes on chronic transfusion therapy. Pediatric Blood & Cancer. 67(9). e28499–e28499. 3 indexed citations

Semova, Ivana, Amy E. Levenson, Joanna Krawczyk, et al.. (2019). Type 1 diabetes is associated with an increase in cholesterol absorption markers but a decrease in cholesterol synthesis markers in a young adult population. Journal of clinical lipidology. 13(6). 940–946. 21 indexed citations

Levenson, Amy E., Carly E. Milliren, Sudha B. Biddinger, et al.. (2017). Calorically restricted diets decrease PCSK9 in overweight adolescents. Nutrition Metabolism and Cardiovascular Diseases. 27(4). 342–349. 9 indexed citations

Levenson, Amy E., Amy S. Shah, Philip R. Khoury, et al.. (2017). Obesity and type 2 diabetes are associated with elevated PCSK9 levels in young women. Pediatric Diabetes. 18(8). 755–760. 38 indexed citations

Muniyappa, Ranganath, Amy E. Levenson, Mary Walter, et al.. (2016). Effect of Leptin Administration on Circulating Apolipoprotein CIII levels in Patients With Lipodystrophy. The Journal of Clinical Endocrinology & Metabolism. 101(4). 1790–1797. 9 indexed citations

Levenson, Amy E., Mary E. Haas, Ji Miao, et al.. (2016). Effect of Leptin Replacement on PCSK9 in ob/ob Mice and Female Lipodystrophic Patients. Endocrinology. 157(4). 1421–1429. 18 indexed citations

10.

Haas, Mary E., Amy E. Levenson, Xiaowei Sun, et al.. (2016). The Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Nephrotic Syndrome-Associated Hypercholesterolemia. Circulation. 134(1). 61–72. 93 indexed citations

11.

Wu, Shufang, Amy E. Levenson, Alexei Kharitonenkov, & Francesco De Luca. (2012). Fibroblast Growth Factor 21 (FGF21) Inhibits Chondrocyte Function and Growth Hormone Action Directly at the Growth Plate. Journal of Biological Chemistry. 287(31). 26060–26067. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact